Related references
Note: Only part of the references are listed.STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma - Results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience
V. B. Weeda et al.
EUROPEAN JOURNAL OF CANCER (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
The mutational landscape of adenoid cystic carcinoma
Allen S. Ho et al.
NATURE GENETICS (2013)
Molecular Characteristics of Fibrolamellar Hepatocellular Carcinoma
Attila Patonai et al.
PATHOLOGY & ONCOLOGY RESEARCH (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Detecting genomic indel variants with exact breakpoints in single- and paired-end sequencing data using SplazerS
Anne-Katrin Emde et al.
BIOINFORMATICS (2012)
DELLY: structural variant discovery by integrated paired-end and split-read analysis
Tobias Rausch et al.
BIOINFORMATICS (2012)
cAMP-dependent protein kinase is essential for hypoxia-mediated epithelial-mesenchymal transition, migration, and invasion in lung cancer cells
Dooniya Shaikh et al.
CELLULAR SIGNALLING (2012)
Detecting differential usage of exons from RNA-seq data
Simon Anders et al.
GENOME RESEARCH (2012)
A Systematic Review: Treatment and Prognosis of Patients with Fibrolamellar Hepatocellular Carcinoma
Michael N. Mavros et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
High Aromatase Activity and Overexpression of Epidermal Growth Factor Receptor in Fibrolamellar Hepatocellular Carcinoma in a Child
Katsumi Muramori et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
Fibrolamellar Carcinoma: A Review with Focus on Genetics and Comparison to Other Malignant Primary Liver Tumors
Stephen C. Ward et al.
SEMINARS IN LIVER DISEASE (2011)
Identification of fusion genes in breast cancer by paired-end RNA-sequencing
Henrik Edgren et al.
GENOME BIOLOGY (2011)
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
Aaron McKenna et al.
GENOME RESEARCH (2010)
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
Jordi Barretina et al.
NATURE GENETICS (2010)
Analysis and design of RNA sequencing experiments for identifying isoform regulation
Yarden Katz et al.
NATURE METHODS (2010)
Differential expression analysis for sequence count data
Simon Anders et al.
GENOME BIOLOGY (2010)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
Chromosomal changes in fibrolamellar hepatocellular carcinoma detected by array comparative genomic hybridization
Sanjay Kakar et al.
MODERN PATHOLOGY (2009)
SeqAn An efficient, generic C++ library for sequence analysis
Andreas Doering et al.
BMC BIOINFORMATICS (2008)
Review of the clinicopathologic features of fibrolamellar carcinoma
Michael Torbenson
ADVANCES IN ANATOMIC PATHOLOGY (2007)
Autoantibody cancer biomarker: Extracellular protein kinase A
Maria V. Nesterova et al.
CANCER RESEARCH (2006)
Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma
AF Buckley et al.
HUMAN PATHOLOGY (2006)
Outcome of patients with fibrolamellar hepatocellular carcinoma
F Stipa et al.
CANCER (2006)
Protein kinase A-dependent synergism between GATA factors and the nuclear receptor, liver receptor homolog-1, regulates human aromatase (CYP19) PII promoter activity in breast cancer cells
MF Bouchard et al.
ENDOCRINOLOGY (2005)
Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis
S Kakar et al.
MODERN PATHOLOGY (2005)
Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study
HB El-Serag et al.
HEPATOLOGY (2004)
Fibrolamellar hepatocellular carcinoma in children and adolescents
HM Katzenstein et al.
CANCER (2003)
Phosphorylation of the stress-activated protein kinase, MEKK3, at serine 166
DG Adams et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2002)
Cytogenetic aberrations in primary and recurrent fibrolamellar hepatocellular carcinoma detected by comparative genomic hybridization
L Wilkens et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2000)
Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients
AS Marchio et al.
ONCOGENE (2000)
14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation
SR Datta et al.
MOLECULAR CELL (2000)
Share Paper
